logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Wednesday, March 19, 2025 · 795,089,604 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Viiv Healthcare News Monitoring

  • Published on Mar 17, 2025

    ViiV Healthcare Presents Potential Long-Acting HIV Therapies

    At CROI 2025, held March 9-12 in San Francisco, we spoke with researchers from ViiV Healthcare about the latest findings from ongoing phase 1 studies of VH184, an integrase strand transfer inhibitor (INSTI), and VH499, a novel HIV-1 capsid inhibitor. The …

    Source: ContagionLive - Label Pending
  • Published on Mar 17, 2025

    CROI 2025: Key Updates on ViiV Healthcare’s Cabenuva and Apretude

    The 2025 Conference on Retroviruses and Opportunistic Infections (CROI), which was held March 9 through March 12 in San Francisco, California, showcased updates in 2 key HIV treatment and prevention methods from ViiV Healthcare: cabotegravir/ …

    Source: Pharmacy Times - Neutral
  • Published on Mar 17, 2025

    Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

    N6LS, a broadly neutralising antibody from ViiV Healthcare, could potentially be a partner for cabotegravir (Vocabria) in a long-acting HIV treatment regimen, according to results from the EMBRACE study presented at the Conference on Retroviruses and …

    Source: Aidsmap - Neutral
  • Published on Mar 17, 2025

    New long-acting HIV drugs show promising early results

    Two new long-acting antiretroviral drugs, VH-184 and VH-499, have demonstrated similar potency to the best available antiretrovirals currently in use in phase 2a proof-of-concept trials, according to findings presented at the Conference on Retroviruses and …

    Source: Aidsmap - Neutral
  • Published on Mar 17, 2025

    Two-Drug HIV Therapy Effective Without Resistance Testing

    TOPLINE: Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. METHODOLOGY: Researchers conducted a randomized, noninferiority, …

    Source: Medscape - Neutral
  • Published on Mar 14, 2025

    Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment

    There were zero cases of HIV acquisition for cabotegravir long-acting (CAB LA; Apretude) as pre-exposure prophylaxis (PrEP), according to data presented at the Conference on Retroviruses and Opportunistic Infection (CROI) in San Francisco, California. …

    Source: Drug Topics - Neutral
  • Published on Mar 13, 2025

    ViiV to trial twice-yearly HIV antibody dosing after Phase IIb success

    ViiV Healthcare is looking to investigate twice-yearly dosing of its human immunodeficiency virus (HIV) therapy, which has been able to suppress viral load in patients dosed every four months in a Phase IIb trial. Results from the company’s Embrace trial ( …

    Source: Clinical Trials Arena - Label Pending
  • Published on Mar 17, 2025

    Tecovirimat fails to reduce clade II mpox lesions, pain, viral clearance

    March 17, 2025 3 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The NIH stopped …

    Source: Healio News - Neutral
  • Published on Mar 14, 2025

    Apretude PrEP Shows High Efficacy, Safety in Diverse Studies

    At this week’s CROI conference, ViiV Healthcare presented real-world data on its long-acting injectable PrEP, cabotegravir long-acting (CAB LA), (Apretude). In it’s PILLAR study, there was zero HIV acquisition through 12 months and high persistence with …

    Source: ContagionLive - Neutral
  • Published on Mar 13, 2025

    New Generation of Long-Acting Antiretrovirals Shows Promise

    Early results of two experimental, long-acting antivirals show promise in treating HIV, according to data presented at the Conference on Retroviruses and Opportunistic Infections, which was held in San Francisco from March 9 to 12. The drugs being studied …

    Source: Managed Healthcare Executive - Neutral
  • Published on Mar 14, 2025

    Shortlist announced for the 2025 British Diversity Awards

    SOME OF the UK’s most prominent figures in sport, entertainment, and activism have been shortlisted for the 2025 British Diversity Awards, set to take place in London next week. The annual event, now in its fourth year, which celebrates individuals and …

    Source: The Voice - Left-wing
  • «
  • 1
  • »

  • 0
  • 0
  • 5
  • 5
days
  • 0
  • 0
  • 3
  • 3
hours
:
  • 0
  • 0
  • 7
  • 7
minutes
:
  • 5
  • 5
  • 4
  • 4
seconds

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 795,089,604 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement